Palmitoyl Pentapeptide: Match the Exact Sequence
AXON Research Institute • AXON Peptide affiliation
Educational draft • Scientific + legal review pending
Silent film with full on-screen captions. Conceptual illustrations, not molecular structures.

Palmitoyl pentapeptide is an incomplete identity unless the exact sequence is specified. One published cosmetic trial tested pal-KTTKS, a defined five-amino-acid sequence with a lipid attachment. Ninety-three women participated in a twelve-week, randomized, double-blind split-face study. Researchers compared a moisturizer containing pal-KTTKS with the same moisturizer without it. The tested formulation improved fine-line and wrinkle measurements relative to the control. The evidence concerns that sequence, vehicle, study population and period of observation. It does not establish identical effects for every palmitoylated peptide or finished serum. Matching the ingredient and formulation is essential before transferring a claim.

END CARD
Educational draft. Not medical advice. Sources and limitations accompany this film.

SOURCES
[1] Robinson et al. (2005): Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin
https://pubmed.ncbi.nlm.nih.gov/18492182/
Primary randomized double-blind placebo-controlled split-face human cosmetic trial

EVIDENCE LIMITATIONS
The catalog label does not independently identify a specific product or INCI variant.
The study tested pal-KTTKS in one vehicle; do not generalize to all palmitoylated peptides.
The population was Caucasian women aged 35–55; broader generalizability is limited.

TOPIC INVENTORY PROVENANCE (not reused audiovisual media)
Palmitoyl Pentapeptide: Read the Trial as a Finished-Formula Study